ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/11/21 | 4,920 | 4,944 | 4,815 | 4,823 | -64 | -1.3% | 201,000 |
2024/11/20 | 4,942 | 4,950 | 4,850 | 4,887 | -34 | -0.7% | 158,500 |
2024/11/19 | 4,752 | 4,936 | 4,708 | 4,921 | +144 | +3% | 288,500 |
2024/11/18 | 4,760 | 4,809 | 4,747 | 4,777 | -23 | -0.5% | 234,900 |
2024/11/15 | 4,884 | 4,915 | 4,792 | 4,800 | -84 | -1.7% | 329,100 |
2024/11/14 | 4,862 | 4,912 | 4,833 | 4,884 | -25 | -0.5% | 189,600 |
2024/11/13 | 4,906 | 4,946 | 4,853 | 4,909 | -45 | -0.9% | 215,300 |
2024/11/12 | 5,000 | 5,049 | 4,898 | 4,954 | +89 | +1.8% | 475,600 |
2024/11/11 | 4,862 | 4,933 | 4,804 | 4,865 | +73 | +1.5% | 312,500 |
2024/11/08 | 4,890 | 4,948 | 4,729 | 4,792 | -168 | -3.4% | 702,100 |
2024/11/07 | 4,929 | 4,995 | 4,811 | 4,960 | +40 | +0.8% | 777,200 |
2024/11/06 | 4,862 | 4,968 | 4,825 | 4,920 | +60 | +1.2% | 248,700 |
2024/11/05 | 4,670 | 4,878 | 4,620 | 4,860 | -20 | -0.4% | 448,400 |
2024/11/01 | 4,932 | 5,000 | 4,870 | 4,880 | -127 | -2.5% | 234,300 |
2024/10/31 | 5,092 | 5,097 | 4,971 | 5,007 | -63 | -1.2% | 322,300 |
2024/10/30 | 5,049 | 5,116 | 5,034 | 5,070 | +47 | +0.9% | 900,600 |
2024/10/29 | 4,972 | 5,037 | 4,910 | 5,023 | +73 | +1.5% | 333,000 |
2024/10/28 | 4,918 | 4,972 | 4,880 | 4,950 | +48 | +1% | 235,800 |
2024/10/25 | 4,887 | 4,910 | 4,834 | 4,902 | -21 | -0.4% | 318,100 |
2024/10/24 | 4,859 | 4,934 | 4,833 | 4,923 | +27 | +0.6% | 232,500 |
2024/10/23 | 4,911 | 4,959 | 4,889 | 4,896 | -16 | -0.3% | 158,600 |
2024/10/22 | 4,896 | 4,934 | 4,890 | 4,912 | -10 | -0.2% | 277,800 |
2024/10/21 | 4,893 | 4,937 | 4,858 | 4,922 | +35 | +0.7% | 304,200 |
2024/10/18 | 4,905 | 4,930 | 4,882 | 4,887 | +6 | +0.1% | 229,000 |
2024/10/17 | 4,955 | 4,955 | 4,852 | 4,881 | -65 | -1.3% | 345,100 |
2024/10/16 | 4,944 | 5,050 | 4,940 | 4,946 | +33 | +0.7% | 321,900 |
2024/10/15 | 4,933 | 4,945 | 4,870 | 4,913 | -12 | -0.2% | 357,400 |
2024/10/11 | 4,981 | 4,990 | 4,906 | 4,925 | -67 | -1.3% | 348,100 |
2024/10/10 | 5,000 | 5,019 | 4,926 | 4,992 | +28 | +0.6% | 357,400 |
2024/10/09 | 5,042 | 5,057 | 4,925 | 4,964 | +20 | +0.4% | 492,600 |
2024/10/08 | 5,030 | 5,138 | 4,935 | 4,944 | -65 | -1.3% | 717,200 |
2024/10/07 | 4,900 | 5,016 | 4,877 | 5,009 | +123 | +2.5% | 638,100 |
2024/10/04 | 4,746 | 4,890 | 4,730 | 4,886 | +140 | +2.9% | 620,400 |
2024/10/03 | 4,874 | 4,920 | 4,708 | 4,746 | -58 | -1.2% | 1,226,600 |
2024/10/02 | 4,700 | 4,871 | 4,691 | 4,804 | +114 | +2.4% | 815,000 |
2024/10/01 | 4,565 | 4,690 | 4,541 | 4,690 | +178 | +3.9% | 763,000 |
2024/09/30 | 4,449 | 4,561 | 4,431 | 4,512 | +41 | +0.9% | 754,400 |
2024/09/27 | 4,425 | 4,517 | 4,420 | 4,471 | -50 | -1.1% | 515,900 |
2024/09/26 | 4,400 | 4,530 | 4,381 | 4,521 | +180 | +4.1% | 869,800 |
2024/09/25 | 4,230 | 4,375 | 4,220 | 4,341 | +100 | +2.4% | 567,500 |
2024/09/24 | 4,125 | 4,254 | 4,105 | 4,241 | +270 | +6.8% | 759,400 |
2024/09/20 | 3,977 | 3,989 | 3,950 | 3,971 | +21 | +0.5% | 331,100 |
2024/09/19 | 3,950 | 3,975 | 3,941 | 3,950 | +54 | +1.4% | 142,600 |
2024/09/18 | 3,861 | 3,900 | 3,859 | 3,896 | +30 | +0.8% | 196,800 |
2024/09/17 | 3,889 | 3,910 | 3,820 | 3,866 | +6 | +0.2% | 251,700 |
2024/09/13 | 3,844 | 3,875 | 3,840 | 3,860 | -2 | -0.1% | 182,600 |
2024/09/12 | 3,859 | 3,923 | 3,822 | 3,862 | +59 | +1.6% | 191,700 |
2024/09/11 | 3,941 | 3,941 | 3,777 | 3,803 | -138 | -3.5% | 176,200 |
2024/09/10 | 3,959 | 3,984 | 3,934 | 3,941 | +1 | ±0% | 234,400 |
2024/09/09 | 3,863 | 3,952 | 3,820 | 3,940 | +7 | +0.2% | 274,400 |
1~
50
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 482,300円 | +22.6% | +68.1% | 2.82% | 12.85倍 | 1.24倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
ロート | 274,500円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 166,400円 | 0.0% | +50.6% | 2.04% | 17.73倍 | 1.99倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
久光薬 | 428,400円 | +7.3% | -3.8% | 2.10% | 19.89倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 256,300円 | +56.7% | +357.2% | 0.00% | 23.73倍 | 5.65倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム